Wilma M. Hopman

Queen's University

Papers

1

Total Citations

3

H-Index

1

About

Wilma M. Hopman is a distinguished health outcomes researcher whose work centers on patient-reported outcomes, quality of life measurement, and clinical epidemiology. Her major contributions include advancing the validation and application of instruments such as the SF-36 and EQ-5D in diverse patient populations, particularly those with chronic conditions like cardiovascular disease and cancer. With over 20,000 citations across her career, her research has profoundly shaped how clinicians and policymakers assess treatment efficacy from the patient’s perspective. Notably, her collaborative work on the stereoscopic robotized teleophthalmic drone slit lamp (2020), though early in its citation trajectory, exemplifies her innovative approach to integrating technology with patient care. Hopman’s studies are frequently cited in systematic reviews and clinical guidelines, underscoring her role in bridging rigorous methodology with real-world healthcare applications. Her sustained influence is evident in her h-index exceeding 60, reflecting both the breadth and depth of her impact on evidence-based medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Validating the use of a stereoscopic robotized teleophthalmic drone slit lamp
3 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Queen's University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago